RxDoctor Payments Data

Jessica Wiedemann, NP

Family · Fort Wayne, INNPI 1093256950

Payments from drug & device makers

$621in general payments, 2019–2025

Across 29 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spinal Simplicity, LLC$208
  • AbbVie$168
  • Lundbeck LLC$90
  • Collegium Pharmaceutical, Inc.$76
  • Pfizer$50
  • Antares Pharma, Inc.$15
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$621100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$621 in reported general payments places this provider in the 55th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$44,485
Medicare patients
220
Services billed
1,451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate49$43,619
OxycontinOxycodone Hcl21$20,956
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen407$18,586
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen343$10,294
BelbucaBuprenorphine Hcl11$9,356
MovantikNaloxegol Oxalate16$6,937
Buprenorphine24$4,970
Fentanyl23$4,922
Pregabalin178$4,882
Oxycodone Hcl144$4,756
Gabapentin208$2,712
Lidocaine20$2,056
Morphine Sulfate ErMorphine Sulfate48$1,724
Methocarbamol94$1,414
Diclofenac Sodium35$1,366

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$76$52,97560 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,392 family providers in Indiana.

Other family in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →